Global Subcutaneous Injection Market Research Report 2023

A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.

The global Subcutaneous Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Subcutaneous Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Subcutaneous Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Subcutaneous Injection in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection.

The Subcutaneous Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Subcutaneous Injection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Subcutaneous Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Subcutaneous Injection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Subcutaneous Injection Equipment

1.2.3 Subcutaneous Injection Drug

1.2.4 Others

1.3 Market by Application

1.3.1 Global Subcutaneous Injection Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Laboratory

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Subcutaneous Injection Market Perspective (2018-2029)

2.2 Subcutaneous Injection Growth Trends by Region

2.2.1 Global Subcutaneous Injection Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Subcutaneous Injection Historic Market Size by Region (2018-2023)

2.2.3 Subcutaneous Injection Forecasted Market Size by Region (2024-2029)

2.3 Subcutaneous Injection Market Dynamics

2.3.1 Subcutaneous Injection Industry Trends

2.3.2 Subcutaneous Injection Market Drivers

2.3.3 Subcutaneous Injection Market Challenges

2.3.4 Subcutaneous Injection Market Restraints

3.1 Global Top Subcutaneous Injection Players by Revenue

3.1.1 Global Top Subcutaneous Injection Players by Revenue (2018-2023)

3.1.2 Global Subcutaneous Injection Revenue Market Share by Players (2018-2023)

3.2 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Subcutaneous Injection Revenue

3.4 Global Subcutaneous Injection Market Concentration Ratio

3.4.1 Global Subcutaneous Injection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Injection Revenue in 2022

3.5 Subcutaneous Injection Key Players Head office and Area Served

3.6 Key Players Subcutaneous Injection Product Solution and Service

3.7 Date of Enter into Subcutaneous Injection Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Subcutaneous Injection Historic Market Size by Type (2018-2023)

4.2 Global Subcutaneous Injection Forecasted Market Size by Type (2024-2029)

5.1 Global Subcutaneous Injection Historic Market Size by Application (2018-2023)

5.2 Global Subcutaneous Injection Forecasted Market Size by Application (2024-2029)

6.1 North America Subcutaneous Injection Market Size (2018-2029)

6.2 North America Subcutaneous Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Subcutaneous Injection Market Size by Country (2018-2023)

6.4 North America Subcutaneous Injection Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Subcutaneous Injection Market Size (2018-2029)

7.2 Europe Subcutaneous Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Subcutaneous Injection Market Size by Country (2018-2023)

7.4 Europe Subcutaneous Injection Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Subcutaneous Injection Market Size (2018-2029)

8.2 Asia-Pacific Subcutaneous Injection Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Subcutaneous Injection Market Size by Region (2018-2023)

8.4 Asia-Pacific Subcutaneous Injection Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Subcutaneous Injection Market Size (2018-2029)

9.2 Latin America Subcutaneous Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Subcutaneous Injection Market Size by Country (2018-2023)

9.4 Latin America Subcutaneous Injection Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Subcutaneous Injection Market Size (2018-2029)

10.2 Middle East & Africa Subcutaneous Injection Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Subcutaneous Injection Market Size by Country (2018-2023)

10.4 Middle East & Africa Subcutaneous Injection Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Becton Dickinson

11.1.1 Becton Dickinson Company Detail

11.1.2 Becton Dickinson Business Overview

11.1.3 Becton Dickinson Subcutaneous Injection Introduction

11.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2018-2023)

11.1.5 Becton Dickinson Recent Development

11.2 Daiichi Sankyo

11.2.1 Daiichi Sankyo Company Detail

11.2.2 Daiichi Sankyo Business Overview

11.2.3 Daiichi Sankyo Subcutaneous Injection Introduction

11.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2018-2023)

11.2.5 Daiichi Sankyo Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Subcutaneous Injection Introduction

11.3.4 Sanofi Revenue in Subcutaneous Injection Business (2018-2023)

11.3.5 Sanofi Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Subcutaneous Injection Introduction

11.4.4 Roche Revenue in Subcutaneous Injection Business (2018-2023)

11.4.5 Roche Recent Development

11.5 GSK

11.5.1 GSK Company Detail

11.5.2 GSK Business Overview

11.5.3 GSK Subcutaneous Injection Introduction

11.5.4 GSK Revenue in Subcutaneous Injection Business (2018-2023)

11.5.5 GSK Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Subcutaneous Injection Introduction

11.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2018-2023)

11.6.5 Eli Lilly Recent Development

11.7 Asahi Kasei Pharma

11.7.1 Asahi Kasei Pharma Company Detail

11.7.2 Asahi Kasei Pharma Business Overview

11.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction

11.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2018-2023)

11.7.5 Asahi Kasei Pharma Recent Development

11.8 Takeda Pharmaceutical

11.8.1 Takeda Pharmaceutical Company Detail

11.8.2 Takeda Pharmaceutical Business Overview

11.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction

11.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2018-2023)

11.8.5 Takeda Pharmaceutical Recent Development

11.9 Antares Pharma, Inc.

11.9.1 Antares Pharma, Inc. Company Detail

11.9.2 Antares Pharma, Inc. Business Overview

11.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction

11.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2018-2023)

11.9.5 Antares Pharma, Inc. Recent Development

11.10 Eisai Co.，Ltd

11.10.1 Eisai Co.，Ltd Company Detail

11.10.2 Eisai Co.，Ltd Business Overview

11.10.3 Eisai Co.，Ltd Subcutaneous Injection Introduction

11.10.4 Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2018-2023)

11.10.5 Eisai Co.，Ltd Recent Development

11.11 Chugai Pharmaceutical

11.11.1 Chugai Pharmaceutical Company Detail

11.11.2 Chugai Pharmaceutical Business Overview

11.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction

11.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2018-2023)

11.11.5 Chugai Pharmaceutical Recent Development

11.12 Endo International

11.12.1 Endo International Company Detail

11.12.2 Endo International Business Overview

11.12.3 Endo International Subcutaneous Injection Introduction

11.12.4 Endo International Revenue in Subcutaneous Injection Business (2018-2023)

11.12.5 Endo International Recent Development

11.13 PenJet Corporation

11.13.1 PenJet Corporation Company Detail

11.13.2 PenJet Corporation Business Overview

11.13.3 PenJet Corporation Subcutaneous Injection Introduction

11.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2018-2023)

11.13.5 PenJet Corporation Recent Development

11.14 Aspen Medical Group

11.14.1 Aspen Medical Group Company Detail

11.14.2 Aspen Medical Group Business Overview

11.14.3 Aspen Medical Group Subcutaneous Injection Introduction

11.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2018-2023)

11.14.5 Aspen Medical Group Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Subcutaneous Injection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Subcutaneous Injection Equipment

    Table 3. Key Players of Subcutaneous Injection Drug

    Table 4. Key Players of Others

    Table 5. Global Subcutaneous Injection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Subcutaneous Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Subcutaneous Injection Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Subcutaneous Injection Market Share by Region (2018-2023)

    Table 9. Global Subcutaneous Injection Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Subcutaneous Injection Market Share by Region (2024-2029)

    Table 11. Subcutaneous Injection Market Trends

    Table 12. Subcutaneous Injection Market Drivers

    Table 13. Subcutaneous Injection Market Challenges

    Table 14. Subcutaneous Injection Market Restraints

    Table 15. Global Subcutaneous Injection Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Subcutaneous Injection Market Share by Players (2018-2023)

    Table 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2022)

    Table 18. Ranking of Global Top Subcutaneous Injection Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Subcutaneous Injection Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Subcutaneous Injection Product Solution and Service

    Table 22. Date of Enter into Subcutaneous Injection Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Subcutaneous Injection Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Subcutaneous Injection Revenue Market Share by Type (2018-2023)

    Table 26. Global Subcutaneous Injection Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Subcutaneous Injection Revenue Market Share by Type (2024-2029)

    Table 28. Global Subcutaneous Injection Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Subcutaneous Injection Revenue Market Share by Application (2018-2023)

    Table 30. Global Subcutaneous Injection Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Subcutaneous Injection Revenue Market Share by Application (2024-2029)

    Table 32. North America Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Subcutaneous Injection Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Subcutaneous Injection Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Subcutaneous Injection Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Subcutaneous Injection Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Subcutaneous Injection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Subcutaneous Injection Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Subcutaneous Injection Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Subcutaneous Injection Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Subcutaneous Injection Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Subcutaneous Injection Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Subcutaneous Injection Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Becton Dickinson Company Detail

    Table 48. Becton Dickinson Business Overview

    Table 49. Becton Dickinson Subcutaneous Injection Product

    Table 50. Becton Dickinson Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 51. Becton Dickinson Recent Development

    Table 52. Daiichi Sankyo Company Detail

    Table 53. Daiichi Sankyo Business Overview

    Table 54. Daiichi Sankyo Subcutaneous Injection Product

    Table 55. Daiichi Sankyo Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 56. Daiichi Sankyo Recent Development

    Table 57. Sanofi Company Detail

    Table 58. Sanofi Business Overview

    Table 59. Sanofi Subcutaneous Injection Product

    Table 60. Sanofi Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 61. Sanofi Recent Development

    Table 62. Roche Company Detail

    Table 63. Roche Business Overview

    Table 64. Roche Subcutaneous Injection Product

    Table 65. Roche Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 66. Roche Recent Development

    Table 67. GSK Company Detail

    Table 68. GSK Business Overview

    Table 69. GSK Subcutaneous Injection Product

    Table 70. GSK Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 71. GSK Recent Development

    Table 72. Eli Lilly Company Detail

    Table 73. Eli Lilly Business Overview

    Table 74. Eli Lilly Subcutaneous Injection Product

    Table 75. Eli Lilly Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 76. Eli Lilly Recent Development

    Table 77. Asahi Kasei Pharma Company Detail

    Table 78. Asahi Kasei Pharma Business Overview

    Table 79. Asahi Kasei Pharma Subcutaneous Injection Product

    Table 80. Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 81. Asahi Kasei Pharma Recent Development

    Table 82. Takeda Pharmaceutical Company Detail

    Table 83. Takeda Pharmaceutical Business Overview

    Table 84. Takeda Pharmaceutical Subcutaneous Injection Product

    Table 85. Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 86. Takeda Pharmaceutical Recent Development

    Table 87. Antares Pharma, Inc. Company Detail

    Table 88. Antares Pharma, Inc. Business Overview

    Table 89. Antares Pharma, Inc. Subcutaneous Injection Product

    Table 90. Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 91. Antares Pharma, Inc. Recent Development

    Table 92. Eisai Co.，Ltd Company Detail

    Table 93. Eisai Co.，Ltd Business Overview

    Table 94. Eisai Co.，Ltd Subcutaneous Injection Product

    Table 95. Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 96. Eisai Co.，Ltd Recent Development

    Table 97. Chugai Pharmaceutical Company Detail

    Table 98. Chugai Pharmaceutical Business Overview

    Table 99. Chugai Pharmaceutical Subcutaneous Injection Product

    Table 100. Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 101. Chugai Pharmaceutical Recent Development

    Table 102. Endo International Company Detail

    Table 103. Endo International Business Overview

    Table 104. Endo International Subcutaneous Injection Product

    Table 105. Endo International Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 106. Endo International Recent Development

    Table 107. PenJet Corporation Company Detail

    Table 108. PenJet Corporation Business Overview

    Table 109. PenJet Corporation Subcutaneous Injection Product

    Table 110. PenJet Corporation Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 111. PenJet Corporation Recent Development

    Table 112. Aspen Medical Group Company Detail

    Table 113. Aspen Medical Group Business Overview

    Table 114. Aspen Medical Group Subcutaneous Injection Product

    Table 115. Aspen Medical Group Revenue in Subcutaneous Injection Business (2018-2023) & (US$ Million)

    Table 116. Aspen Medical Group Recent Development

    Table 117. Research Programs/Design for This Report

    Table 118. Key Data Information from Secondary Sources

    Table 119. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Subcutaneous Injection Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Subcutaneous Injection Market Share by Type: 2022 VS 2029

    Figure 3. Subcutaneous Injection Equipment Features

    Figure 4. Subcutaneous Injection Drug Features

    Figure 5. Others Features

    Figure 6. Global Subcutaneous Injection Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Subcutaneous Injection Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Case Studies

    Figure 9. Clinic Case Studies

    Figure 10. Laboratory Case Studies

    Figure 11. Others Case Studies

    Figure 12. Subcutaneous Injection Report Years Considered

    Figure 13. Global Subcutaneous Injection Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Subcutaneous Injection Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Subcutaneous Injection Market Share by Region: 2022 VS 2029

    Figure 16. Global Subcutaneous Injection Market Share by Players in 2022

    Figure 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Injection Revenue in 2022

    Figure 19. North America Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Subcutaneous Injection Market Share by Country (2018-2029)

    Figure 21. United States Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Subcutaneous Injection Market Share by Country (2018-2029)

    Figure 25. Germany Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Subcutaneous Injection Market Share by Region (2018-2029)

    Figure 33. China Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Subcutaneous Injection Market Share by Country (2018-2029)

    Figure 41. Mexico Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Subcutaneous Injection Market Share by Country (2018-2029)

    Figure 45. Turkey Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Subcutaneous Injection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Becton Dickinson Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 48. Daiichi Sankyo Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 49. Sanofi Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 50. Roche Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 51. GSK Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 52. Eli Lilly Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 53. Asahi Kasei Pharma Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 55. Antares Pharma, Inc. Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 56. Eisai Co.，Ltd Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 57. Chugai Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 58. Endo International Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 59. PenJet Corporation Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 60. Aspen Medical Group Revenue Growth Rate in Subcutaneous Injection Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed